Latest news from SEQENS Group

All news

Events General PERSONAL CARE Press release Products & Technologies Protéus SD-CSR

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis

Seqens confirms the acquisition of CELLforCURE

New investments in China

Seqens group at DCAT Week 2023

Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston

Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.

DCAT 2022: a success for Seqens group

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory

Meeting with Virginie Tarlet for the International Women’s Day

Meeting with Yael Gofni for the International Women’s Day

Update on isopropanol plant expansion

SK Capital becomes the new majority shareholder of Seqens – Q&A

1 2 3 4 … 11

Contact